Tharimmune, Inc.
THAR
$1.10
-$0.05-4.35%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 14.53% | 16.71% | 3.03% | -20.68% | 42.02% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 52.00% | 109.51% | 0.38% | -13.52% | 43.30% |
Operating Income | -52.00% | -109.51% | -0.38% | 13.52% | -43.30% |
Income Before Tax | -54.44% | -108.55% | 0.50% | 16.08% | -40.05% |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -54.44% | -108.55% | 0.50% | 16.08% | -40.05% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -54.44% | -108.55% | 0.50% | 16.08% | -40.05% |
EBIT | -52.00% | -109.51% | -0.38% | 13.52% | -43.30% |
EBITDA | -- | -- | -- | -- | -- |
EPS Basic | 79.99% | 93.78% | 95.36% | 96.71% | 81.39% |
Normalized Basic EPS | 79.99% | 93.78% | 95.36% | 96.71% | 81.39% |
EPS Diluted | 79.99% | 93.78% | 95.36% | 96.71% | 81.39% |
Normalized Diluted EPS | 79.99% | 93.78% | 95.36% | 96.71% | 81.39% |
Average Basic Shares Outstanding | 671.94% | 3,249.13% | 2,042.76% | 2,453.42% | 653.42% |
Average Diluted Shares Outstanding | 671.94% | 3,249.13% | 2,042.76% | 2,453.42% | 653.42% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |